Earnings History Data for Nemaura Medical (NMRD) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Nemaura Medical
Nemaura Medical Inc. is a medical technology company. It engages in developing and commercializing non-invasive wearable diagnostic devices. The company is currently commercializing sugarBEAT(R), BEAT(TM) diabetes, and proBEAT(TM). SugarBEAT(R), a CE mark approved Class IIb medical device, is a non-invasive and flexible continuous glucose monitor. Nemaura Medical Inc. is based in New York, United States.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 14-08-2023 | PM | NMRD | Nemaura Medical | 22.00 | -0.09 | -0.14 | 0.00 | Nemaura Medical GAAP EPS of -$0.09 beats by $0.06 [8/14/2023 12:45 PM] |
0.7968 | 0.02 (2.15%) |
0.88 | 0.10 (12.82%) |
0.48 - 3.43 | 185,127 | 30,000 | 9,355 | ||
| 15-11-2022 | PM | 8:30 AM ET (Nov 15) |
NMRD | Nemaura Medical | 58.00 | -0.17 | -0.17 | 0.00 | Nemaura Medical GAAP EPS of -$0.17 in-line, revenue of $0.07M misses by $0.06M [11/15/2022 8:26 AM] |
2.10 | -0.13 (-5.83%) |
0.0 | 0.0 (0.00%) |
1.50 - 5.94 | 9,830 | 10,000 | 0 | |
| 30-06-2022 | PM | NMRD | Nemaura Medical | 63.00 | -0.15 | -0.15 | 0.00 | Nemaura Medical GAAP EPS of -$0.59 misses by $0.12, revenue of $0.51M [6/30/2022 9:31 AM] |
2.57 | -0.05 (-1.91%) |
0.0 | 0.0 (0.00%) |
2.15 - 10.87 | 2,567 | 0 | 0 | ||
| 11-02-2022 | ?? | NMRD | Nemaura Medical Inc. | 96.15 | -0.15 | 0.00 | -0.06 | Nemaura Medical GAAP EPS of -$0.15, revenue of $0.18M [2/14/2022 8:20 AM] |
4.20 | 0.01 (0.24%) |
0.0 | 0.0 (0.00%) |
3.57 - 17.40 | 6,028 | 50,000 | 0 | ||
| 29-06-2021 | PM | NMRD | Nemaura Medical Inc. | 232.60 | -0.09 | 0.00 | -0.06 | Nemaura Medical EPS beats by $0.02 [6/30/2021 8:55 AM] |
10.18 | -0.51 (-4.77%) |
10.50 | -0.19 (-1.78%) |
3.12 - 17.40 | 148,479 | 400,000 | 1,655 | ||
|
||||||||||||||||||
| 16-02-2021 | PM | NMRD | Nemaura Medical Inc. | 186.35 | -0.06 | 0.00 | -0.02 | Nemaura Medical reports Q3 results [2/16/2021 8:50 AM] |
7.92 | -0.22 (-2.70%) |
7.85 | -0.07 (-0.88%) |
3.02 - 16.50 | 420,027 | 996,279 | 3,316 | ||